The Uromigos Episode 52: World Tour Final Stop—Boston With David McDermott

By The Uromigos - Last Updated: July 24, 2020

Dr. David McDermott joins the Uromigos to discuss biomarkers in renal cancer in the era of immune therapy.

Post Tags:Uromigos-Kidney Cancer

Related Podcasts

Episode 412: AUA 2025 - TAR-200 Monotherapy in BCG-Unresponsive NMIBC From SunRISe-1n

Uromigos-Bladder Cancer

Episode 411: Live From EIKCS in Amsterdam - RCC Highlights

Uromigos-Kidney Cancer

Episode 410: AUA 2025 - BOND-003 Cohort C: Cretostimogene in BCG-Unresponsive NMIBC

Uromigos-Bladder Cancer

Episode 409: AUA 2025 - CREST - BCG +/- Sasanlimab in High-Risk NMIBC

Uromigos-Bladder Cancer

Episode 407: Drug Development in China: Part 2 of 2

Advertisement

Advertisement